Clinical Trial Update: Chromium Picolinate for the Treatment of Metabolic Syndrome [NA]

View source ↗

Summary

This trial update notes that a NCCIH-sponsored study evaluating chromium picolinate for metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome
• Obesity
• Prediabetes

Drugs mentioned

• Chromium Picolinate (chromium picolinate)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Metabolic Syndrome X, Prediabetic State | NA | Status: COMPLETED